Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

A woman’s story about being asked an unexpected question during a job interview has gone viral on social media, sparking discussion about honesty, self-awareness, and workplace values. The post, ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

To stand out in today's job market, it's crucial to go "one step beyond" other candidates by polishing your personal narrative and preparing for tricky interview questions. Candidates who are able to ...

Our Bartleby columnist asked readers of his newsletter for a favourite job interview question, one that reliably says the most about a candidate. Here is a selection of their replies, edited for ...

The Supreme Court used the doctrine, which requires Congress to speak clearly to confer vast economic power, to strike down several Biden administration programs. By Adam Liptak Reporting from ...

Getting ready for a Java interview in 2025? It can feel like a lot, especially with so many different things to know. Whether you’re just starting out or you’ve been coding for a while, this guide is ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...